Kang Young Sill, Park Eun-Kyung, Kim Yong-Oock, Kim Ju-Seong, Kim Dong-Seok, Thomale U W, Shim Kyu-Won
Division of Pediatric Neurosurgery, Charité Universitätsmedizin, Berlin, Germany.
Department of Neurosurgery, Universitätsmedizin, Mainz, Germany.
Childs Nerv Syst. 2017 May;33(5):767-775. doi: 10.1007/s00381-017-3370-9. Epub 2017 Mar 22.
The object of this study is to understand abnormal dynamic of cerebrospinal fluid (CSF) in patients with neurofibromatosis type 1 (NF1), which may cause temporal lobe herniation and bulging of temporal fossa.
Four patients, three females and one male, with NF1 were studied retrospectively. They presented with a similar craniofacial deformity, which consisted of pulsatile exophthalmos, an enlarged bony orbit, dysplasia of the sphenoid wing with the presence of a herniation of the temporal lobe into the orbit, and a bulging temporal fossa.
Surgical exploration demonstrated abnormally thickened arachnoid membrane in one case. Protruding temporal lobe, which was one of the main symptoms in NF1 patients, could be stopped by control of intracranial pressure (ICP) via programmable ventriculoperitoneal shunt (VPS) or extra ventricle drainage implantation. The dense fibrosis of the arachnoid membrane and consequent altered hemispheric CSF dynamics may cause symptoms including pulsatile exophthalmos and consequent worsening of vision, prolapse of the temporal lobe, and enlargement of the temporal fossa. This finding may not present with general features of hydrocephalus, so that delays in diagnosis often result.
For the NF1 patients with cranio-orbito-temporal deformities, prior to any surgical reconstruction, control of increased ICP (IICP) should be primarily considered.
本研究的目的是了解1型神经纤维瘤病(NF1)患者脑脊液(CSF)的异常动力学,这可能导致颞叶疝和颞窝膨出。
回顾性研究了4例NF1患者,其中3例女性,1例男性。他们表现出相似的颅面畸形,包括搏动性眼球突出、眶骨增大、蝶骨翼发育不良伴颞叶疝入眼眶以及颞窝膨出。
手术探查发现1例蛛网膜异常增厚。NF1患者的主要症状之一——颞叶突出,可通过可编程脑室腹腔分流术(VPS)或脑室外引流植入术控制颅内压(ICP)来缓解。蛛网膜的致密纤维化以及随之改变的半球脑脊液动力学可能导致搏动性眼球突出及视力恶化、颞叶脱垂和颞窝扩大等症状。这一发现可能不具有脑积水的一般特征,因此常常导致诊断延误。
对于患有颅眶颞畸形的NF1患者,在进行任何手术重建之前,应首先考虑控制颅内压升高(IICP)。